Merrimack Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company specializes in the development and sale of innovative pharmaceutical products. One of their notable achievements includes the sale of ONIVYDE® to Ipsen S.

A. While Merrimack Pharmaceuticals does not currently engage in research or development activities, they continue to facilitate their operations through external consultants. Despite not having any employees, their commitment to delivering high-quality healthcare solutions remains unwavering.

The company's dedication to excellence is reflected in their commitment to corporate governance. They have a well-structured board of directors and committees, ensuring transparency and accountability. Merrimack Pharmaceuticals' stock information, including stock quotes, historical data, and investment calculators, can be accessed on their website.

Moreover, their Investor FAQs provide additional information and clarity for potential investors. For further inquiries or to get in touch, you can contact Merrimack Pharmaceuticals through their provided email address or visit them at their office located at One Broadway, 14th floor, Cambridge, MA. Visit their website for more details on their privacy policy and terms of use